Kcentra
Generic name: Prothrombin Complex
Drug class:
Anticoagulant reversal agents
Usage of Kcentra
Kcentra is a blood coagulation factor replacement product.
Kcentra is used to quickly reverse the effects of a blood-thinning medicine (such as Warfarin) during a major bleeding episode, or when there is a need for emergency surgery or invasive medical procedure.
Kcentra is for use in adults and dosing is based on body weight.
Kcentra side effects
Get emergency medical help if you have signs of an allergic Reaction to Kcentra: hives, rash; nausea, vomiting, feeling light-headed; fast heartbeats; chest tightness, wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers right away if you have:
Common Kcentra side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Kcentra
You should not be treated with Kcentra if you have:
If possible before you receive Kcentra, tell your caregivers if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
Kcentra is made from donated human plasma and may contain viruses or other infectious agents. Donated plasma is tested and treated to reduce the risk of contamination, but there is still a small possibility it could transmit disease. Ask your doctor about any possible risk.
Relate drugs
- Andexxa
- Coagulation factor Xa
- Coagulation factor xa recombinant, inactivated-zhzo
- Balfaxar
- Idarucizumab
- Kcentra
- Praxbind
- Prothrombin complex
- Prothrombin complex human
- Prothrombin complex human-lans
How to use Kcentra
Usual Adult Dose for Reversal of Acquired Coagulation Factor Deficiency:
INR 2 to less than 4: 25 units of Factor IX/kg body weight given intravenously INR 4 to 6: 35 units of Factor IX/kg body weight given intravenously INR greater than 6: 50 units of Factor IX/kg body weight given intravenously Maximum dose: INR 2 to less than 4: 2500 units of Factor IX INR 4 to 6: 3500 units of Factor IX INR greater than 6: 5000 units of Factor IX Duration of therapy: Single dose. Repeat dosing is not supported by clinical data and is not recommended. Comments: -Administer Vitamin K concurrently to maintain Vitamin K Dependent clotting factor levels once the effects of Kcentra concentrate have diminished. -Individualize dosing based on the patient's current predose International Normalized Ratio (INR) value, and body weight. -Dose is based on body weight up to but not exceeding 100 kg. Do not exceed stated maximum dose for patients weighing more than 100 kg. -Dosing is based on actual potency. The potency varies from vial to vial and is stated on the carton. Potency varies from 20-31 Factor IX units/mL. Nominal potency is 500 units per vial or approximately 25 units per mL after reconstitution.
Warnings
While using Kcentra, tell your caregivers right away if you have signs of a blood clot: sudden numbness or weakness, problems with vision or speech, chest pain, cough, wheezing, rapid breathing, swelling or pain in your arms, legs, or stomach.
Tell your doctor if you have ever had a heart attack, stroke, TIA or "mini-stroke", chest pain, severe circulation problems, or a blood clot (especially within the past 3 months).
Kcentra is for use in people who use blood thinners such as warfarin. After you are treated with this medicine, do not start using your blood thinner again until your doctor tells you to.
What other drugs will affect Kcentra
Other drugs may interact with prothrombin complex, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions